Novel <i>SBF2</i> mutations and clinical spectrum of Charcot‐Marie‐Tooth neuropathy type 4B2
Petra Laššuthová(Northwestern University), Jan Senderek(Friedrich Baur Stiftung), Joachim Weis(Universitätsklinikum Aachen), Wolfgang Müller‐Felber(Ludwig-Maximilians-Universität München), Lucie Sedláčková(Masaryk University), Beate Schlotter‐Weigel(Friedrich Baur Stiftung), Rita Horváth(University of Cambridge), Sevim Erdem‐Özdamar(Hacettepe University), Katharina Vill(Ludwig-Maximilians-Universität München), Radim Mazanec(Charles University), Jana Neupauerová(Charles University), Haluk Topaloğlu(Yeditepe University), Pavel Seeman, Dieter Gläser(Genetikum), David Staněk(Charles University), J. M. Schröder(Maastricht University), Boglárka Bánsági(Wellcome Centre for Mitochondrial Research)
Cited by 12
Related Papers
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
|Nature Genetics|2004|1.6k
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
GJB2 Mutations and Degree of Hearing Loss: A Multicenter Study
|The American Journal of Human Genetics|2005|562
Nesprin-1 and -2 are involved in the pathogenesis of Emery–Dreifuss muscular dystrophy and are critical for nuclear envelope integrity
|Human Molecular Genetics|2007|543